Diabetes: Renal benefits of lowering BP in the absence of hypertension.
Regardless of baseline blood pressure, treatment with a combination of an angiotensin-converting enzyme inhibitor and a diuretic decreases incidence of renal events in patients with type 2 diabetes. The combination therapy approach could be the key to achieving renoprotection.
Suzuki
Hiromichi
H
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D004232:Diuretics / Q000627:therapeutic use*; D006801:Humans; D006977:Hypertension, Renal / Q000517:prevention & control*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics